Trial Profile
Apatinib Treatment for Advanced Esophagus Cancer ,One-armed Exploratory Openting , Clinical Trail.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 24 Sep 2019
Price :
$35
*
At a glance
- Drugs Rivoceranib (Primary)
- Indications Oesophageal cancer; Squamous cell cancer
- Focus Therapeutic Use
- 05 Jun 2017 New trial record